34.236.192.4
dgid:
enl:
npi:0
Home Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapies: Updates in Diabetic Eye Diseases, Retinal Vein Occlusion and Age-Related Macular Degeneration – A Four-Part Series

Continuing Medical Education

Facebook
Twitter
LinkedIn
Email

Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapies: Updates in Diabetic Eye Diseases, Retinal Vein Occlusion and Age-Related Macular Degeneration – A Four-Part Series

Read More
By rd360stg
October 19: Practical Management of Inherited Retinal Disorders
May 5, 2020
By rd360stg
Dry Eye Disease Management for Improving Patient Outcomes
October 17, 2019
By rd360stg
Evolving Diabetic Retinopathy Management Strategies to Prevent Vision Loss
October 17, 2019
By rd360stg
Optimizing Treatment of Neovascular AMD: Do Fluid Subtypes Matter?
October 17, 2019
By rd360stg
Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
September 9, 2019
By rd360stg
The Young Patient: Challenges During Cataract Surgery
September 9, 2019
By rd360stg
Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
September 9, 2019
By rd360stg
Transitioning Treatment in Diabetic Retinopathy
September 9, 2019
By rd360stg
Putting Knowledge Into Practice: Uveitis Clinical Case Scenarios
June 11, 2019
By rd360stg
New Minimally Invasive Glaucoma Surgery Options
June 11, 2019
By rd360stg
Controlling Floppy Iris and Zonular Laxity With Capsule Retractors
June 11, 2019
By rd360stg
Advances in Cataract Surgical Techniques and Postoperative Care
June 11, 2019

Contact

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]

QUICK LINKS

Social Links

© 2022 IHM. Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights Reserved